Source: Osha.gov | Receipt Date: 2021-06-01
501 Chouteau Avenue, St Louis, Missouri, United States
Updated:
Source: Osha.gov | Receipt Date: 2021-06-01
Recent Interesting Reports
Scam, Cloverdale Ct, Statesville, NC, USA
4 weeks ago •reported by user-tfhv7513
746 South GlasGow Ave Inglewood CA 90301
A package I didn't order, Granbury, TX, USA
3 weeks ago •reported by user-rcjd6867
Scam, Lexington, KY 40503, USA
3 weeks ago •reported by user-prkj4722
Scam KetoGenesis Las Vegas, Titusville, FL, USA
3 weeks ago •reported by user-vxnbm942
I’m reporting this to the owner of the business, Rancho Cucamonga, CA, USA
3 weeks ago •reported by user-bkmt6716
Package I didn't order, Seymour, MO, USA
2 days ago •reported by user-rpzm2696
Received daily detox did not order, Jamestown, TN, USA
1 week ago •reported by user-qwdky314
AvKARE, LLC Atovaquone Oral Suspension - recalled due to potential Bacillus cereus contamination, USA
3 weeks ago •source www.fda.gov
Recall notice
Risk Statement: In the population most at risk, immunocompromised population, there is a reasonable probability that microbial contamination of Atovaquone Oral Suspension can result in disseminated, life threatening infections such as endocarditis and necrotizing soft tissue infections.
Atovaquone Oral Suspension, USP is indicated for prevention and treatment of Pneumocystis jiroveci pneumonia (PCP) in adults and children 13 years of age and older who cannot tolerate other medicines, such as trimethoprim-sulfamethoxazole.
The product is packaged in a carton. The identified NDC # associated with the product is 50268-086-12, UPC # 5026808612 and the affected lot# is AW0221A with an expiration date of 08/2025.
AvKARE, LLC is notifying its distributors and wholesale customers by mailings and email communications method and is arranging for returns of all recalled Atovaquone Oral Suspension, USP. Wholesalers who have Atovaquone Oral Suspension, USP 750mg/5mL, which are being recalled, should examine their inventory and cease dispensing, return any of the impacted lots to AvKARE, LLC. Consumers that have product which is being recalled should stop using the product and return it to place of purchase.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
In case you experience harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.
Company name: AvKARE, LLC
Brand name: AVpak
Product recalled: Atovaquone Oral Suspension, USP 750mg/5mL
Reason of the recall: Potential Bacillus cereus contamination
FDA Recall date: April 01, 2024
Source: www.fda.gov
I ordered a sweatshirt and got a amarata jacket, Bucuresti ,str Aleea Lunca Siretului,nr 1A,sector 6
3 weeks ago •reported by user-ydfg4319
Unordered Package, Hamilton Township, NJ, USA
2 weeks ago •reported by user-zcwn4673
Report by
IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)
Visit our learn pages for more helpful information or, email us: support@safelyhq.com